CClinicalTrials.gg
Active, not recruitingNCT04152824RESULTUpdated Apr 8, 2025Results posted

Readiness Supportive Leadership Training

An interventional study of Resilience-Supportive Leadership Training (RESULT) in Health Behavior and Well-Being, sponsored by Oregon Health and Science University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-08.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,890
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a randomized controlled trial that assesses the effects of an evidence based, multi-component, leadership support intervention, Resilience-Supportive Leadership Training (RESULT), using accelerated learning strategies aimed at improving Service Member resilience and readiness in the military.

The intervention is expected to increase perceptions of resilience-supportive behaviors, resilience indicators, and related behavioral health outcomes such as emotion regulation, connectedness, team cohesion, and psychological health following the training from the perspective of the Service Member.

Read the detailed description

The goal of our proposed study is to adapt our existing, evidence-based supportive leadership training for an active duty population, focusing on training junior leaders in the Army on ways they can enhance readiness and resilience in their soldiers, as well as their own resilience. The investigators draw on best practices from existing military and civilian programs in a training that is engaging, interactive, and customizable. The investigators use micro-learnings - small, bite-sized pieces of information delivered in non-traditional ways, such as short podcasts or videos to enhance the training and enable it to be integrated easily into both military and civilian jobs.

The investigators evaluate the effectiveness of our Resilience-Supportive Leadership Training (RESULT) intervention with U.S. Army soldiers stationed at Joint Base Lewis-McChord (JBLM) in the State of Washington. The study includes a control group, so the investigators can better determine whether any observed changes in our participants are due to our training programs, and not some other factor. The investigators anticipate that the training programs will have a positive impact on service member readiness and resilience, psychological health, team cohesion, and reduced loneliness.

This research is designed to benefit not only U.S. Army soldiers but across all military branches, as well as first-responders and other civilian occupations that face highly stressful situations as part of their work. Our training has the potential to positively contribute to the military by enhancing service member readiness and unit autonomy, and improving mental and physical health.

02

Conditions studied

  • Health Behavior
  • Well-Being

Keywords

  • Psychological Health
  • Well-Being
  • Resilience
  • Readiness
  • Military
  • Service Member
03

In context

Lead sponsor

Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Active Duty Service Members Serving in one of the two Striker Brigade Combat Teams (SBCT).

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
1,890 participants (actual)

Study arms

  • Experimental
    Training Group Units

    Units randomized to the intervention group will go through the Resilience-Supportive Leadership Training (RESULT)

    Behavioral: Resilience-Supportive Leadership Training (RESULT)

  • No intervention
    Control Group

    Units randomized to the control group will be usual practice regarding resiliency training

Interventions

  • BehavioralResilience-Supportive Leadership Training (RESULT)

    Platoon leaders receive a 90-minute, in-person training addressing supportive supervisor behaviors and resilience

06

What researchers measure

Primary outcomes

  1. Resilience Supportive Supervisor Behaviors - Emotional Support

    Service member's perceptions of leadership emotional support behavior. Likert-type scale 1-5, with higher scores indicating greater support

    Time frame: 3-month post intervention, up to 4 months

  2. Resilience Supportive Supervisor Behaviors - Destigmatizing

    Service member's perceptions of leadership support behavior in destigmatizing behavioral health. Likert-type scale 1-5, with higher scores indicating greater destigmatization

    Time frame: 3-month post intervention, up to 4 months

  3. Dimensions of Anger Reactions (DAR-5)

    Service member's perceptions of their anger, Likert-type scale 1-5 with higher scores indicating higher levels of anger

    Time frame: 3-month post intervention, up to 4 months

  4. Life Satisfaction

    Service member's perceptions of their general life satisfaction. Likert-type scale from 1-5, with higher scores indicating higher satisfaction

    Time frame: 3-month post intervention, up to 4 months

  5. Unit Belonging - Subscale of the Team Cohesion Scale

    Service member's perceptions degree to which they feel part of their current platoon. Likert-type scale from 1-7, with higher scores indicating more sense of belonging.

    Time frame: 3-month post intervention, up to 4 months

  6. Brief Loneliness Scale

    Service member's perception of their own loneliness. Likert-type scale from 3-13, with higher scores indicating greater loneliness

    Time frame: 3-month post intervention, up to 4 months

07

Results

Posted Apr 8, 2025

Participant flow

Recruitment of Service Members at all levels within the participating Battalions occurred during the month of September 2019. An Operations Order was delivered to Battalion leaders to send out an email, created by the research team, which explained the study, that participation was voluntary and confidential, and provided a link to an online survey. These emails were forwarded from the Battalion leadership to lower ranking leaders, who then sent to their individual unit members.

Participant flow — Overall Study
MilestoneService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Started948942
Completed118158
Not completed830784

Outcome measures

PrimaryResilience Supportive Supervisor Behaviors - Emotional Support

Service member's perceptions of leadership emotional support behavior. Likert-type scale 1-5, with higher scores indicating greater support

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Resilience Supportive Supervisor Behaviors - Emotional Support
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Resilience Supportive Supervisor Behaviors - Emotional Support4.00 ± .923.90 ± 1.06
PrimaryResilience Supportive Supervisor Behaviors - Destigmatizing

Service member's perceptions of leadership support behavior in destigmatizing behavioral health. Likert-type scale 1-5, with higher scores indicating greater destigmatization

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Resilience Supportive Supervisor Behaviors - Destigmatizing
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Resilience Supportive Supervisor Behaviors - Destigmatizing4.03 ± .863.94 ± 1.03
PrimaryDimensions of Anger Reactions (DAR-5)

Service member's perceptions of their anger, Likert-type scale 1-5 with higher scores indicating higher levels of anger

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Dimensions of Anger Reactions (DAR-5)
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Dimensions of Anger Reactions (DAR-5)1.51 ± .661.71 ± .84
PrimaryLife Satisfaction

Service member's perceptions of their general life satisfaction. Likert-type scale from 1-5, with higher scores indicating higher satisfaction

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Life Satisfaction
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Life Satisfaction3.23 ± 1.043.13 ± .98
PrimaryUnit Belonging - Subscale of the Team Cohesion Scale

Service member's perceptions degree to which they feel part of their current platoon. Likert-type scale from 1-7, with higher scores indicating more sense of belonging.

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Unit Belonging - Subscale of the Team Cohesion Scale
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Unit Belonging - Subscale of the Team Cohesion Scale5.69 ± 1.65.36 ± 1.81
PrimaryBrief Loneliness Scale

Service member's perception of their own loneliness. Likert-type scale from 3-13, with higher scores indicating greater loneliness

Time frame:
3-month post intervention, up to 4 months
Reported as:
Mean · score on a scale
Brief Loneliness Scale
score on a scaleService Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control Condition
Brief Loneliness Scale6.21 ± 2.626.53 ± 2.74

Adverse events

Collected over Data collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Service Member in Battalion Randomized to Intervention Condition0/948 (0%)0/948 (0%)0/948 (0%)
Service Member in Battalion Randomized to Control Condition0/942 (0%)0/942 (0%)0/942 (0%)

Baseline characteristics

Service members in a randomized battalion

Age, Continuous
Age, Continuous(years)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Mean23.5 ± 4.4224.4 ± 5.0123.9 ± 4.70
Sex: Female, Male
Sex: Female, Male(Participants)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Female100144244
Male14822
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
White & Non-White/Multiple — White5883141
White & Non-White/Multiple — Non-White/Multiple selected/Missing6075135
Region of Enrollment
Region of Enrollment(participants)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
United States118158276
Loneliness
Loneliness(units on a scale)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Mean6.44 ± 2.646.45 ± 2.586.45 ± 2.60
Dimensions of Anger (DAR-5)
Dimensions of Anger (DAR-5)(units on a scale)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Mean1.62 ± .691.79 ± .861.71 ± .79
Emotional Support from Leader
Emotional Support from Leader(units on a scale)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Mean3.88 ± .914.01 ± .973.95 ± .95
Life Satisfaction
Life Satisfaction(units on a scale)Service Member in Battalion Randomized to Intervention ConditionService Member in Battalion Randomized to Control ConditionTotal
Mean3.26 ± 1.003.15 ± 1.113.19 ± 1.06

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Joint Base Lewis McChord
    Tacoma, Washington 98433, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 12, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04152824
Lead sponsor
Oregon Health and Science University
Collaborators
Portland State University
Responsible party
Leslie Hammer (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
Nov 5, 2019
Start date
Sep 2, 2019
Primary completion
Feb 8, 2021
Completion
Aug 2025 (estimated)
Results posted
Apr 8, 2025
Last update
Apr 8, 2025

Study contacts

Leslie Hammer, PhD
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion